Tobacco cessation within TB programmes: A ‘real world’ solution for countries with dual burden of disease

Projektinformationen

TB and Tobacco

ID Finanzhilfevereinbarung: 680995

DOI

10.3030/680995

Projekt abgeschlossen

EK-Unterschriftsdatum 24 September 2015

Startdatum 1 November 2015

Enddatum 31 Oktober 2019

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten

€ 2 999 828,75

EU-Beitrag

€ 2 999 828,75

Koordiniert durch

UNIVERSITY OF YORK
United Kingdom

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Websites, patent fillings, videos etc. (2)

Project website

To establish a project website

Trial Register - results

Report on status of posting results in the trial register to be submitted at month 42 after completing data analysis and submitting report on the trial

Documents, reports (11)

Process eval report -SH

The findings of the process evaluation summarised and tailored to the specific needs of stakeholders

Report on the trial

A comprehensive report on the randomised controlled trial findings

'Way Forward' report

A final report on the recommendations made at the ‘way forward’ workshops

Process eval report - SC

The findings of the process evaluation reported in one or more scientific articles in international peer-reviewed journals

Interventions and Lessons

A summary of all the intervention materials and lessons learnt on implementation and adaptation of the cessation strategies

Delivery factors report

An inventory of factors (barriers and facilitators) that are likely to be influential in the delivery of tobacco cessation within TB programme context

Scaling up budget

A budget impact analysis of scaling up tobacco cessation strategies within TB programmes

Tobacco use scales

A translated and validated suite of tobacco withdrawal symptoms and dependency scales

Economic Analysis Report

Cost-effectiveness analysis report of cytisine when added to behavioural support for tobacco cessation compared to behavioural support alone

All approvals package

'All approvals package’ for the trial including ethics approval letters from the respective national competent authorities, approval letters from respective national TB Programs (Bangladesh, Nepal, Pakistan), and approval letters for exporting and importing pharmacological agent used in the trial to be submitted at month 12 prior to trial recruitment

Outcome factors report

A report on the contextual factors that predicts outcomes, either positively or negatively, and their implications for policy makers and health professionals

Demonstrators, pilots, prototypes (1)

Intervention materials

Locally appropriate suite of intervention materials for Bangladesh, Nepal and Pakistan

Veröffentlichungen

Peer reviewed articles (6)

Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness–implementation study

Autoren: Melanie Boeckmann, Iveta Nohavova, Omara Dogar, Eva Kralikova, Alexandra Pankova, Kamila Zvolska, Rumana Huque, Razia Fatima, Maryam Noor, Helen Elsey, Aziz Sheikh, Kamran Siddiqi, Daniel Kotz
Veröffentlicht in: BMJ Open, Ausgabe 8/3, 2018, Seite(n) e019878, ISSN 2044-6055
Herausgeber: BMJ Publishing Group
DOI: 10.1136/bmjopen-2017-019878

Measuring fidelity to behavioural support delivery for smoking cessation and its association with outcomes

Autoren: Omara Dogar, Jan R. Boehnke, Fabiana Lorencatto, Trevor A. Sheldon, Kamran Siddiqi
Veröffentlicht in: Addiction, 2019, ISSN 0965-2140
Herausgeber: Blackwell Publishing Inc.
DOI: 10.1111/add.14804

Using behaviour change theory to train health workers on tobacco cessation support for tuberculosis patients: a mixed-methods study in Bangladesh, Nepal and Pakistan

Autoren: Sahil Warsi, Helen Elsey, Melanie Boeckmann, Maryam Noor, Amina Khan, Deepa Barua, Shammi Nasreen, Samina Huque, Rumana Huque, Sudeepa Khanal, Prabin Shrestha, James Newell, Omara Dogar, Kamran Siddiqi
Veröffentlicht in: BMC Health Services Research, Ausgabe 19/1, 2019, ISSN 1472-6963
Herausgeber: BioMed Central
DOI: 10.1186/s12913-019-3909-4

Health worker and patient views on implementation of smoking cessation in routine tuberculosis care

Autoren: Melanie Boeckmann, Sahil Warsi, Maryam Noor, Omara Dogar, Esha Haowa Mustagfira, Fariza Firoze, Raana Zahid, Anne Readshaw, Kamran Siddiqi, Daniel Kotz
Veröffentlicht in: npj Primary Care Respiratory Medicine, Ausgabe 29/1, 2019, ISSN 2055-1010
Herausgeber: Nature Publishing Group
DOI: 10.1038/s41533-019-0146-6

H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases

Autoren: Constantine I. Vardavas, Christina N. Kyriakos, Esteve Fernández, Panagiotis Bamidis, Kamran Siddiqi, Niels H. Chavannes, R.M.J.J. van der Kleij, Gary Parker, Cornel Radu-Loghin, Brian Ward, Karim Berkouk
Veröffentlicht in: European Respiratory Journal, Ausgabe 54/3, 2019, Seite(n) 1901417, ISSN 0903-1936
Herausgeber: European Respiratory Society
DOI: 10.1183/13993003.01417-2019

The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

Autoren: Dogar, Omara Fatima; Barua, Deepa; Boeckmann, Melanie; Elsey, Helen; Fatima, Razia; Gabe, Rhian; Huque, Rumana; Keding, Ada; Khan, Amina; Kotz, Daniel; Kralikova, Eva; Newell, James N; Nohavova, Iveta; Parrott, Steven James; Readshaw, Anne Elizabeth; Renwick, Charlotte; Sheikh, Aziz; Siddiqi, Kamran
Veröffentlicht in: urn:issn:0965-2140, Ausgabe 1, 2018, ISSN 0965-2140
Herausgeber: Blackwell Publishing Inc.
DOI: 10.1111/add.14242